NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SeqWell

SeqWell

Private
Beverly, MassachusettsHealthcare & Life Scienceshttps://seqwell.com/

Last Round

Series C

Extension

Feb 6, 2025

Total Funding Raised

$24.52M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

SeqWell is a biotechnology company that develops and provides next-generation sequencing (NGS) library preparation technologies and kits.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

next-generation sequencingNGSlibrary preparationmultiplexed sequencinggenomicsmolecular biology reagentstransposase chemistryhigh-throughput sequencingDNA library prepgenomics coretargeted sequencingmicrobial genomicswet lablab automationbiotech consumables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SeqWell Comparables

Compare SeqWell with similar companies based on industry and business-model similarity.

SeqWell comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
New England Biolabs
79%
Lexogen
78%
Watchmaker Genomics
77%

SeqWell Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionFeb 6, 2025
Series C ExtensionSep 11, 2023
Series CApr 21, 2022
Series BJan 14, 2020
Series A ExtensionMay 4, 2017
Seed
Jul 15, 2016

SeqWell Investors

Notable investors and investment history

SeqWell investors
InvestorRounds
Research Corporation TechnologiesSeries C, Series B
BroadOak Capital PartnersSeries B, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 46% MoM.

  • Feb 23, 2026

    Launched MosaiX, a next-generation library prep kit for high-throughput genomics.

SeqWell Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SeqWell Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SeqWell's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeverly, Massachusetts
Employee Range38
Year Founded2014
Last FundingFeb 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.